| Accession |
PRJCA012540 |
| Title |
Pharmacokinetic effects of single-center, open, single-arm, fixed-sequence SHR3680 on repaglinide (CYP2C8 substrate) and bupropion (CYP2B6 substrate) in prostate cancer patients |
| Relevance |
Medical |
| Data types |
clinical information,metabolic data,etc
|
| Organisms |
Homo sapiens
|
| Description |
The clinical data and metabolic data produced by the clinical study. |
| Sample scope |
Multiisolate |
| Release date |
2022-10-18 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2022-10-17 |
